CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

The several benefits Of Agricultural Genome Editing

The several benefits Of Agricultural...

Genomics Market is anticipated to reach US$ 49,996.15 Mn by 2027

Genomics Market is anticipated to...

Bionano Genomics Symposium to feature OGM Presentations and Live Panel Discussion

Bionano Genomics Symposium to feature...

What is the Importance of Gene Editing in Farming?

What is the Importance of Gene...

Autolomous and Vineti to Establish a Fully Integrated End-To-End CGT Delivery Pathway Together

Autolomous and Vineti to Establish a...

Genome Editing: What Makes CRISPR-Cas9 a Preferred Choice?

Genome Editing: What Makes...

4 Diseases That Could Be Cured Using CRISPR Technology

4 Diseases That Could Be Cured Using...

Genome Editing Market: Development, Prospective and Regional Vision

Genome Editing Market: Development,...

The several benefits Of Agricultural Genome Editing

The several benefits Of Agricultural...

Genomics Market is anticipated to reach US$ 49,996.15 Mn by 2027

Genomics Market is anticipated to...

Bionano Genomics Symposium to feature OGM Presentations and Live Panel Discussion

Bionano Genomics Symposium to feature...

What is the Importance of Gene Editing in Farming?

What is the Importance of Gene...

Autolomous and Vineti to Establish a Fully Integrated End-To-End CGT Delivery Pathway Together

Autolomous and Vineti to Establish a...

Genome Editing: What Makes CRISPR-Cas9 a Preferred Choice?

Genome Editing: What Makes...

4 Diseases That Could Be Cured Using CRISPR Technology

4 Diseases That Could Be Cured Using...

Genome Editing Market: Development, Prospective and Regional Vision

Genome Editing Market: Development,...

How Can Genome Editing Aid in the Fight Against a Virus?

Life Sciences Review | Monday, August 30, 2021
Tweet

When SARS-CoV-2 was discovered, numerous researchers focused on investigating this novel virus and the disease it caused.


FREMONT, CA: CRISPR researchers were no exception, and the gene-editing technique was quickly thrust into the forefront of the global struggle against COVID-19. The CRISPR—Cas system is based on a naturally existing bacterial gene-editing mechanism that plays a critical role in the prokaryotic defense against viral infection. The issue for researchers now is to determine the optimal way to leverage its inherent potential and enhance it for human benefit.


Here, scientists have indeed risen to the challenge, successfully developing quick diagnostic tests for COVID-19 and obtaining their first US FDA (MD, USA) approval. The research continues as similar tests are being designed for wider clinical use, with numerous businesses vying to fill the ever-widening market gap created by reagents for PCR-based COVID-19 tests running out and testing capacity reducing. Scientists have investigated CRISPR as a possible treatment in other fields, harnessing its tailored enzymatic activity to degrade SARS-CoV-2 RNA and limit viral replication.


CRISPR has been successfully used to combat COVID-19, but what role does it contain in this and future pandemics?


CRISPR-based diagnostics for targeted detection


Testing has been a critical component of many countries' COVID-19 response programs,


with PCR-based testing assuming the role of gold standard diagnostic assays. However, a lengthy wait for findings, a labor-intensive technique, and a rapidly depleting supply of reagents have prompted many to seek alternative testing methods. To keep up with the mass testing techniques that many experts believe are necessary to stop the virus's spread, the development of a quick, at-home diagnostic test may help reverse the tide on the world's ever-growing case count. Many have turned to CRISPR for this purpose, as its ability to target nucleotides makes it ideal for identifying the presence of viral RNA.


The CRISPR SARS-CoV-2 test kit has been granted Emergency Use Authorization by the federal government, allowing it to be utilized in qualified laboratories to test for SARS-CoV-2. The COVID-19 test kit works by training the CRISPR system to detect the SARS-CoV-2 genetic signature using complementary gRNA to a specific region of the viral genome. When a target region is discovered in a sample, the CRISPR system is triggered, releasing a detectable signal — in this example, a fluorescent marker.


While the technology is exciting, CRISPR-based diagnostics are now only available in the laboratory. The true challenge now is to develop a point-of-care testing system capable of performing quick and accurate tests in any situation.


See Also:Top Blockchain Technology Consulting/Services Companies


Weekly Brief

loading
> <
  • DNA Sequencing 2022

    Top Vendors

    Current Issue
  • BioTech Startups 2022

    Top Vendors

    Current Issue
  • DNA Sequencing 2022

    Top Vendors

    Current Issue
  • BioTech Startups 2022

    Top Vendors

    Current Issue

Read Also

Role of Predictive Genomics in Sustainable Healthcare

Role of Predictive Genomics in Sustainable Healthcare

A Conversational AI Approach to Regulatory Intelligence

A Conversational AI Approach to Regulatory Intelligence

A rise in DNA Sequencing Market is expected in coming years

A rise in DNA Sequencing Market is expected in coming years

Omniabio Inc. Announces Private Investor

Omniabio Inc. Announces Private Investor
Data analysis for next-generation sequencing worth USD1.2 billion by 2026 - Cloud-based platforms emerging as preferred solutions

Data analysis for next-generation sequencing worth USD1.2 billion by 2026 - Cloud-based platforms emerging as preferred solutions

Lithuania's Vision to Become a Biotech Hub in Europe

Lithuania's Vision to Become a Biotech Hub in Europe

Bridging the Diversity Gap in Genomics

Bridging the Diversity Gap in Genomics

How does Biotechnology Provide Solutions to Human Needs?

How does Biotechnology Provide Solutions to Human Needs?
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/how-can-genome-editing-aid-in-the-fight-against-a-virus-nwid-530.html